|
Real-time Estimate
Tradegate
10:10:58 22/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 123.63 EUR | 0.00% |
|
-2.58% | +20.55% |
| 08:33pm | Celldex shares slip as safety concerns cloud skin drug trial win | RE |
| 08:00pm | European Pharma Leaders Push for National Reforms to Boost Investment | DJ |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.26% | +2.73% | -6.40% | +5.90% | +8.60% | +54.59% | +111.99% | +411.20% | +1,335.69% | 1,03800Cr | ||
| -0.45% | +0.23% | -1.92% | +15.79% | +29.41% | +53.73% | +66.86% | +63.37% | +124.18% | 65TCr | ||
| +0.61% | +1.06% | +0.49% | +15.57% | +16.34% | +19.42% | +74.04% | +149.81% | +308.46% | 47TCr | ||
| -0.19% | +0.97% | -1.70% | +14.28% | +10.94% | +34.30% | +45.99% | +7.07% | +48.55% | 36TCr | ||
| +0.28% | +2.30% | -8.13% | -3.18% | +6.26% | +18.47% | +26.67% | +51.98% | +46.95% | 27TCr | ||
| +0.89% | +4.59% | +4.64% | -4.65% | -8.11% | +10.19% | +14.72% | +47.06% | +145.72% | 26TCr | ||
| +3.53% | +8.41% | -8.24% | +18.14% | +24.42% | +42.40% | +52.13% | +90.62% | +131.89% | 21TCr | ||
| -0.46% | -6.20% | -13.52% | -13.72% | -20.43% | -32.46% | -59.65% | -19.45% | +70.26% | 18TCr | ||
| +1.45% | +4.11% | +3.80% | +21.97% | +24.09% | +35.40% | +103.05% | +113.38% | +86.84% | 19TCr | ||
| +0.31% | +0.87% | -0.64% | +10.81% | +11.61% | +15.60% | -14.99% | -36.77% | -18.62% | 16TCr | ||
| +2.47% | +1.71% | -4.41% | +12.13% | +15.45% | +36.62% | +49.75% | +184.05% | +468.19% | 13TCr | ||
| +0.19% | -1.61% | -6.80% | +14.63% | +16.25% | +39.41% | +6.46% | +4.25% | +11.14% | 13TCr | ||
| -0.27% | +0.24% | -4.97% | +2.62% | -10.07% | -7.28% | -27.14% | -10.08% | +7.92% | 10TCr | ||
| -0.26% | +2.80% | +0.82% | -0.96% | +4.47% | +26.14% | +24.75% | +6.70% | -7.53% | 10TCr | ||
| +0.93% | +5.18% | -3.78% | -10.65% | -18.16% | -1.17% | +58.17% | +63.38% | +461.39% | 7.05TCr | ||
| +0.37% | +4.03% | +3.54% | +20.96% | +23.43% | +33.27% | +25.59% | +58.77% | +25.27% | 6.05TCr | ||
| +1.06% | +1.72% | +2.21% | +29.78% | +33.88% | +80.44% | +4.01% | +6.42% | -46.27% | 5.52TCr | ||
| -1.77% | +0.25% | +1.63% | +19.24% | +37.54% | +96.75% | +286.54% | +300.71% | -22.93% | 4.67TCr | ||
| -0.70% | +5.96% | -4.23% | -5.58% | -23.25% | -34.36% | +4.17% | -2.62% | +183.00% | 4.54TCr | ||
| Average | +0.44% | +1.17% | -2.51% | +8.58% | +9.61% | +27.45% | +44.90% | +78.41% | +176.85% | 23.76TCr | |
| Weighted average by Cap. | +0.41% | +1.30% | -3.25% | +8.93% | +11.80% | +34.09% | +58.82% | +142.76% | +406.32% |
- Stock Market
- Stocks
- NOVN Stock
- NOVN Stock
- Sector Novartis
Select your edition
All financial news and data tailored to specific country editions
















